Art

J-GLOBAL ID：202202267694004700   Reference number：22A0090346

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease

心血管疾患患者における心血管疾患リスク予測のための循環バイオマーカー【JST・京大機械翻訳】

Author (5)： Wong Yuen-Kwun (Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China) ,  Tse Hung-Fat (Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China) ,  Tse Hung-Fat (Department of Medicine, Shenzhen Hong Kong University Hospital, Shenzhen, China) ,  Tse Hung-Fat (Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, The University of Hong Kong, Hong Kong, China) ,  Tse Hung-Fat (Shenzhen Institutes of Research and Innovation, The University of Hong Kong, Hong Kong, China)
Material： Frontiers in Cardiovascular Medicine (Web)
Volume： 8  Page： 713191  Publication year： 2021 
JST Material Number： U7061A  ISSN： 2297-055X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Cardiovascular disease (CVD) i...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A0090346&from=J-GLOBAL&jstjournalNo=U7061A") }}

Thesaurus term： optimization ,  heart ,  *cardiovascular disease ,  *cardiovascular system ,  troponin ,  coronary artery disease ,  fatty acid binding protein ,  *biomarker ,  risk factor ,  cause of death ,  risk assessment ,  adiponectin
Semi thesaurus term： 二次予防 ,  リポカリン ,  心血管イベント , 【Automatic Indexing@JST】

Author keywords (8)： adipocyte ,  B-type natriuretic peptide ,  cardiac troponin ,  coronary artery disease ,  fibroblast growth factor ,  lipocalin ,  plasminogen activator inhibitor ,  risk prediction

JST classification (2)： Cardiovascular system diseases  (GJ03000C) ,  Epidemiology  (GB03000E)

Reference (135)：

• D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart study. Circulation. (2008) 117:743-53. doi: 10.1161/CIRCULATIONAHA.107.699579
• Omland T, White HD. State of the art: blood biomarkers for risk stratification in patients with stable ischemic heart disease. Clin Chem. (2017) 63:165-76. doi: 10.1373/clinchem.2016.255190
• Nadar SK, Shaikh MM. Biomarkers in routine heart failure clinical care. Card Fail Rev. (2019) 5:50-6. doi: 10.15420/cfr.2018.27.2
• Salvagno GL, Pavan C. Prognostic biomarkers in acute coronary syndrome. Ann Transl Med. (2016) 4:258. doi: 10.21037/atm.2016.06.36
• Lindholm D, Lindback J, Armstrong PW, Budaj A, Cannon CP, Granger CB, et al. Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease. J Am Coll Cardiol. (2017) 70:813-26. doi: 10.1016/j.jacc.2017.06.030

Terms in the title (5)： 心血管疾患 ,  患者 ,  リスク予測 ,  循環 ,  バイオマーカー